Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.
Identifieur interne : 000767 ( PubMed/Corpus ); précédent : 000766; suivant : 000768Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.
Auteurs : I A Oreagba ; S O Usman ; S O Olayemi ; K A Oshikoya ; O. Opanuga ; T A Adeyemo ; O A Lesi ; A N Dodoo ; A S AkanmuSource :
- Ghana medical journal [ 0016-9560 ] ; 2014.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Anti-Retroviral Agents (adverse effects), Anti-Retroviral Agents (therapeutic use), Antiretroviral Therapy, Highly Active (adverse effects), Cough (chemically induced), Drug Prescriptions, Female, HIV Infections (drug therapy), Hospitals, Teaching, Humans, Male, Medication Adherence, Middle Aged, Nigeria, Pharmacoepidemiology, Retrospective Studies, Treatment Failure, Young Adult.
- MESH :
- chemical , adverse effects : Anti-Retroviral Agents.
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Nigeria.
- adverse effects : Antiretroviral Therapy, Highly Active.
- chemically induced : Cough.
- drug therapy : HIV Infections.
- Adolescent, Adult, Aged, Drug Prescriptions, Female, Hospitals, Teaching, Humans, Male, Medication Adherence, Middle Aged, Pharmacoepidemiology, Retrospective Studies, Treatment Failure, Young Adult.
Abstract
Prescribing, adherence, and adverse drug events to HAART in a large antiretroviral programme in Lagos was evaluated.
PubMed: 25709134
Links to Exploration step
pubmed:25709134Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.</title><author><name sortKey="Oreagba, I A" sort="Oreagba, I A" uniqKey="Oreagba I" first="I A" last="Oreagba">I A Oreagba</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003 ; National Pharmacovigilance Centre, National Agency for Food and Drug Administration and Control, Abuja, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Usman, S O" sort="Usman, S O" uniqKey="Usman S" first="S O" last="Usman">S O Usman</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Olayemi, S O" sort="Olayemi, S O" uniqKey="Olayemi S" first="S O" last="Olayemi">S O Olayemi</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Oshikoya, K A" sort="Oshikoya, K A" uniqKey="Oshikoya K" first="K A" last="Oshikoya">K A Oshikoya</name><affiliation><nlm:affiliation>Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Opanuga, O" sort="Opanuga, O" uniqKey="Opanuga O" first="O" last="Opanuga">O. Opanuga</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Adeyemo, T A" sort="Adeyemo, T A" uniqKey="Adeyemo T" first="T A" last="Adeyemo">T A Adeyemo</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Lesi, O A" sort="Lesi, O A" uniqKey="Lesi O" first="O A" last="Lesi">O A Lesi</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Dodoo, A N" sort="Dodoo, A N" uniqKey="Dodoo A" first="A N" last="Dodoo">A N Dodoo</name><affiliation><nlm:affiliation>Centre for Clinical Pharmacology and Therapeutics University of Ghana Medical School Accra Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Akanmu, A S" sort="Akanmu, A S" uniqKey="Akanmu A" first="A S" last="Akanmu">A S Akanmu</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25709134</idno><idno type="pmid">25709134</idno><idno type="wicri:Area/PubMed/Corpus">000767</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000767</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.</title><author><name sortKey="Oreagba, I A" sort="Oreagba, I A" uniqKey="Oreagba I" first="I A" last="Oreagba">I A Oreagba</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003 ; National Pharmacovigilance Centre, National Agency for Food and Drug Administration and Control, Abuja, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Usman, S O" sort="Usman, S O" uniqKey="Usman S" first="S O" last="Usman">S O Usman</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Olayemi, S O" sort="Olayemi, S O" uniqKey="Olayemi S" first="S O" last="Olayemi">S O Olayemi</name><affiliation><nlm:affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Oshikoya, K A" sort="Oshikoya, K A" uniqKey="Oshikoya K" first="K A" last="Oshikoya">K A Oshikoya</name><affiliation><nlm:affiliation>Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Opanuga, O" sort="Opanuga, O" uniqKey="Opanuga O" first="O" last="Opanuga">O. Opanuga</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Adeyemo, T A" sort="Adeyemo, T A" uniqKey="Adeyemo T" first="T A" last="Adeyemo">T A Adeyemo</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</nlm:affiliation></affiliation></author><author><name sortKey="Lesi, O A" sort="Lesi, O A" uniqKey="Lesi O" first="O A" last="Lesi">O A Lesi</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</nlm:affiliation></affiliation></author><author><name sortKey="Dodoo, A N" sort="Dodoo, A N" uniqKey="Dodoo A" first="A N" last="Dodoo">A N Dodoo</name><affiliation><nlm:affiliation>Centre for Clinical Pharmacology and Therapeutics University of Ghana Medical School Accra Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Akanmu, A S" sort="Akanmu, A S" uniqKey="Akanmu A" first="A S" last="Akanmu">A S Akanmu</name><affiliation><nlm:affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Ghana medical journal</title><idno type="ISSN">0016-9560</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Anti-Retroviral Agents (adverse effects)</term><term>Anti-Retroviral Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active (adverse effects)</term><term>Cough (chemically induced)</term><term>Drug Prescriptions</term><term>Female</term><term>HIV Infections (drug therapy)</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Medication Adherence</term><term>Middle Aged</term><term>Nigeria</term><term>Pharmacoepidemiology</term><term>Retrospective Studies</term><term>Treatment Failure</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Nigeria</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cough</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Drug Prescriptions</term><term>Female</term><term>Hospitals, Teaching</term><term>Humans</term><term>Male</term><term>Medication Adherence</term><term>Middle Aged</term><term>Pharmacoepidemiology</term><term>Retrospective Studies</term><term>Treatment Failure</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prescribing, adherence, and adverse drug events to HAART in a large antiretroviral programme in Lagos was evaluated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25709134</PMID><DateCreated><Year>2015</Year><Month>02</Month><Day>24</Day></DateCreated><DateCompleted><Year>2015</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2015</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-9560</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Ghana medical journal</Title><ISOAbbreviation>Ghana Med J</ISOAbbreviation></Journal><ArticleTitle>Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.</ArticleTitle><Pagination><MedlinePgn>194-203</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Prescribing, adherence, and adverse drug events to HAART in a large antiretroviral programme in Lagos was evaluated.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective 5 year open cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">The AIDS Prevention Initiative in Nigeria (APIN) clinic at LUTH is one of the United States Presidential Emergency Plan for AIDS Relief (PEP-FAR) funded centers for HIV relief program in Nigeria Participants The case files of 390 patients on HAART and attending the APIN clinic were reviewed sequel to random selection.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Demographics of the patients and pattern of antiretroviral (ARV) combination drugs prescribed were extracted from their case files. The details of the adverse drug events (ADEs) were extracted from drug toxicity forms regularly filled for each patient. A Chi-square test with Yates correction was used to determine the association between adherence and therapeutic outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2944 prescriptions were assessed. Zidovudine + lamivudine + nevirapine (35.87%) and stavudine + lamivudine + nevirapine (35.63%) were the most frequently prescribed combinations. Over 2000 ADEs were reported with cough (13.3%), fever (8.75%) and skin rashes (8.01%) being the most frequently reported. Drug adherence was associated with good therapeutic outcome (χ(2) = 115.60, p<0.0001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Zidovudine + lamivudine + nevirapine was the most frequently prescribed ARV combination. Cough was the most frequently reported ADE. Interventions aimed at rational prescribing of ARV drugs and improving adherence to antiretroviral drugs is essential for good therapeutic outcome in the treatment of HIV infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oreagba</LastName><ForeName>I A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003 ; National Pharmacovigilance Centre, National Agency for Food and Drug Administration and Control, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usman</LastName><ForeName>S O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olayemi</LastName><ForeName>S O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria, 12003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshikoya</LastName><ForeName>K A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opanuga</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeyemo</LastName><ForeName>T A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lesi</LastName><ForeName>O A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodoo</LastName><ForeName>A N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Centre for Clinical Pharmacology and Therapeutics University of Ghana Medical School Accra Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akanmu</LastName><ForeName>A S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>AIDS Prevention Initiative in Nigeria (APIN) Clinic, Lagos University Teaching Hospital, Lagos, Nigeria, 12003 ; Department of Haematology and Blood Transfusion, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ghana</Country><MedlineTA>Ghana Med J</MedlineTA><NlmUniqueID>0073210</NlmUniqueID><ISSNLinking>0016-9560</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2000 Mar 31;14(5):499-507</RefSource><PMID Version="1">10780712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Pharmacol. 2013 Mar-Apr;45(2):145-8</RefSource><PMID Version="1">23716890</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2001 Jan;32(1):124-9</RefSource><PMID Version="1">11118391</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2001 Mar 1;26 Suppl 1:S51-9</RefSource><PMID Version="1">11265001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2001 Jul 6;15(10):1261-8</RefSource><PMID Version="1">11426070</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2001 Oct 15;33(8):1417-23</RefSource><PMID Version="1">11550118</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2001 Sep 28;15(14):1843-8</RefSource><PMID Version="1">11579247</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hepatology. 2002 Jan;35(1):182-9</RefSource><PMID Version="1">11786975</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2002 Mar 30;324(7340):757</RefSource><PMID Version="1">11923157</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Jul 5;16(10):1341-9</RefSource><PMID Version="1">12131210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2003 Jun;17 Suppl 2:S3-26</RefSource><PMID Version="1">12870523</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2003 Oct 17;17(15):2209-14</RefSource><PMID Version="1">14523278</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CMAJ. 2004 Jan 20;170(2):229-38</RefSource><PMID Version="1">14734438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S80-9</RefSource><PMID Version="1">14986279</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2004 Jul 15;39(2):248-55</RefSource><PMID Version="1">15307035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1998 Mar 26;338(13):853-60</RefSource><PMID Version="1">9516219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Ther. 1998 Nov-Dec;20(6):1071-92</RefSource><PMID Version="1">9916603</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 1999 Mar 13;353(9156):863-8</RefSource><PMID Version="1">10093977</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 1999 Jul 20;131(2):81-7</RefSource><PMID Version="1">10419445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2007 Jul 15;45(2):254-60</RefSource><PMID Version="1">17578788</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2007 Oct 15;45(8):1093-101</RefSource><PMID Version="1">17879931</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Antivir Ther. 2007;12(8):1157-64</RefSource><PMID Version="1">18240856</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2008 Mar;24(3):393-9</RefSource><PMID Version="1">18327976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2008 Apr 1;46(7):1111-8</RefSource><PMID Version="1">18444831</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):234-7</RefSource><PMID Version="1">18583790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Microbiol. 2008 Jul-Sep;26(3):256-8</RefSource><PMID Version="1">18695327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Jun 19;24(10):1461-70</RefSource><PMID Version="1">20479637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Fam Physician. 2011 Jun 15;83(12):1443-51</RefSource><PMID Version="1">21671545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2000 Jun;30 Suppl 2:S96-116</RefSource><PMID Version="1">10860894</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006784" MajorTopicYN="N">Hospitals, Teaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017891" MajorTopicYN="N">Pharmacoepidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4335432</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">adverse events</Keyword><Keyword MajorTopicYN="N">antiretroviral drugs</Keyword><Keyword MajorTopicYN="N">drug adherence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25709134</ArticleId><ArticleId IdType="pmc">PMC4335432</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000767 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000767 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25709134
|texte= Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25709134" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |